ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Solvay SA

Solvay SA (SOLB)

31.25
0.22
(0.71%)
Closed November 24 10:30AM

Professional-Grade Tools, for Individual Investors.

Key stats and details

Current Price
31.25
Bid
31.00
Ask
31.50
Volume
138,120
30.80 Day's Range 31.37
17.895 52 Week Range 113.05
Market Cap
Previous Close
31.03
Open
31.23
Last Trade
299
@
31.25
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
214,286
Shares Outstanding
105,876,000
Dividend Yield
-
PE Ratio
1.58
Earnings Per Share (EPS)
19.77
Revenue
11.37B
Net Profit
2.09B

About Solvay SA

Sector
Chems, Allied Pds-whsl, Nec
Industry
Plastics,resins,elastomers
Website
Headquarters
Brussels, Brussels-capital Region, Bel
Founded
1863
Solvay SA is listed in the Chems, Allied Pds-whsl sector of the Euronext with ticker SOLB. The last closing price for Solvay was 31.03 €. Over the last year, Solvay shares have traded in a share price range of 17.895 € to 113.05 €.

Solvay currently has 105,876,000 shares outstanding. The market capitalization of Solvay is 3.29 € billion. Solvay has a price to earnings ratio (PE ratio) of 1.58.

SOLB Latest News

Solvay achieves 100% renewable energy at Rheinberg with second biomass boiler, reducing CO2 emissions by 65%

Solvay achieves 100% renewable energy at Rheinberg with second biomass boiler, reducing CO2 emissions by 65% Brussels, November 21, 2024   The soda ash and bicarbonate plant is now fully powered...

Solvay : résultats de Solvay du troisième trimestre 2024

Solvay : résultats de Solvay du troisième trimestre 2024 Communiqué de presse - Information réglementée publiée le 6 novembre 2024 à 7h00 CET Des performances financières saines avec...

Solvay third quarter 2024 results

Solvay third quarter 2024 results Press release - Regulated information published on November 6, 2024, at 7:00 a.m. CET Sound financial performance with acceleration of costs savingsConfirmation...

Notification de participation par UBS Group AG

Notification de participation par UBS Group AG Bruxelles, le 14 octobre 2024 - 17h45 CEST - Information réglementée Conformément à la législation et réglementation en matière de transparence...

Participation notification by UBS Group AG

Participation notification by UBS Group AG Brussels, October 14, 2024, 17:45 CEST - Regulated information In line with Belgian transparency legislation (Law of May 2, 2007), UBS Group AG recently...

Solvay completes its largest GHG emissions reduction project yet, transforming U.S. Green River operations

Solvay completes its largest GHG emissions reduction project yet, transforming U.S. Green River operations Green River, Wyoming, USA, October 10, 2024   By deploying a new process and phasing out...

Notification de participation par BNP Paribas Asset Management

Notification de participation par BNP Paribas Asset Management Bruxelles, le 4 octobre 2024 - 08h30 CEST - Information réglementée Conformément à la législation et réglementation en matière de...

Participation notification by BNP Paribas Asset Management

Participation notification by BNP Paribas Asset Management Brussels, October 4, 2024, 08:30 CEST - Regulated information In line with Belgian transparency legislation (Law of May 2, 2007), BNP...

Solvay: acquisition d’actions propres et achèvement du programme de rachat d’actions

Solvay: acquisition d’actions propres et achèvement du programme de rachat d’actions Bruxelles, le 1 october 2024 - 18h30 CEST -) Information réglementée Conformément à l'article 8:4 de l'arrêté...

Solvay: acquisition of own shares and completion of the share buyback program

Solvay: acquisition of own shares and completion of the share buyback program Brussels, October 1, 2024, 6:30pm CEST - regulated information In accordance with article 8:4 of the Royal Decree of...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.06-0.19163206643231.3132.7330.3914661831.55551164DE
4-7.38-19.10432306538.6338.930.3922418134.64574804DE
120.060.1923693491531.1939.3730.3921428634.99371025DE
26-2.05-6.1561561561633.339.3729.4723135033.42057956DE
52-72.45-69.8649951784103.7113.0517.89541186130.18156402DE
156-73.25-70.0956937799104.5113.0517.89526625663.16255586DE
260-72.75-69.9519230769104118.6517.89525515870.95191457DE

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
MLAAHAmatheon Agri Holding NV
0.02 €
(100.00%)
5k
GNROGeNeuro SA
0.0768 €
(25.49%)
200
BIDSGascogne DS
0.005 €
(25.00%)
150.51k
ALSAFSAFE
0.11 €
(23.73%)
39.98k
ALKKOKKO International SA
0.112 €
(21.21%)
4.13M
ALIMOGroupimo
0.189 €
(-40.94%)
392
MLUMGUmalis Group
1.30 €
(-31.22%)
1.71k
MLNMAMiguet Et Associes
0.075 €
(-24.62%)
1.72k
MLSEQSequa Petroleum NV
0.008 €
(-20.00%)
23k
VACBSPierre & Vacances
0.05 €
(-15.25%)
35.99k
BCPBanco Comercial Portugues SA
0.4446 €
(-0.49%)
69.24M
ALNEVNeovacs
0.0002 €
(0.00%)
41.4M
ALCYBCybergun
0.0001 €
(0.00%)
30.32M
INGAING Groep NV
14.652 €
(-1.16%)
14.06M
ACACredit Agricole SA
13.05 €
(-1.66%)
8.06M

Discussion

View Full Feed
Truthsocial Truthsocial 6 minutes ago
Can someone who cares do a wellness check on sceeat...family members FDA or BIG Pharma please

Because RDGL and MAYO clinic are soon ready to move up in the outpatient cancer treatment world without sceeat....
RDGL
The ELTP King The ELTP King 7 minutes ago
This is my last post.

Taking a long break for the holidays.

Will return in early January.

Thanks.
ELTP
Murphydog25 Murphydog25 8 minutes ago
Just gave Hitman a DM to talk about this stock going forward so I'm feeling more positive now after his positive words of wisdom 🤗
He also said he's doing well but finding 6 by 6 a small space and his flatmate ron'da snores 🧐
NWPN
Azart Azart 20 minutes ago
My friend what Scamus is currently doing is absolutely not new. This is exactly how everything was transferred from the previous company to becoming Rannever Health back in 2014 or 15 if I am not mistaken. The back then CEO before Scamus did the exact same thing Scamus is doing with Foxo. Common hol
RNVA
SteveSchiets SteveSchiets 25 minutes ago
There was a lot of resistance not acting up on my belief S7 hasn't play it's final hand. The fact that ACC's are used by our competitors made me do that silly thing. Maybe also because other stocks in my portfolio needs more time, i decided to have one last go (it's never the last). If trillions wi
SEV
knrorrel knrorrel 1 hour ago
no chance in the quantum hype, $10 could come quickly now, like on Friday with qmco (+171%, only on Friday increased from $3.60 to $11!)

and it's a shame that they couldn't buy more,

but I feel the same way (I also have far too little of $QBTS but unfortunately I don'
QBTS
chen1992 chen1992 1 hour ago
https://youtu.be/PaMsc8z1Ls4?si=u3MwvbGovNMyWXI6


Inverse Cramer at it again! Did it for TELL!!!!
TGLO
silkmaster silkmaster 1 hour ago
It looks like we can only guss what would the pps will look like in a week/month or a year from now .
Mean while lets play what would the PPS look like come 30/11/24 so long as KT will come out and talk to the public by than that is ...

A. 0.09 (around current pps)
B. 0.
KBLB
ZLAZARUS ZLAZARUS 2 hours ago
Ph3 melanoma data for IO102-IO103 remain on track for 1H25 and represents the next key catalyst. At .70 we are trading at cash. With a positive Ph3 melanoma readout we will be trading at $3.00 overnight with a march to $6.00 towards the later half of 2025. In addition, I'm encouraged by the support
IOBT
knrorrel knrorrel 2 hours ago
https://de.tradingview.com/chart/Mq3nUQ7Y/?symbol=NYSE%3AQBTS
QBTS
knrorrel knrorrel 2 hours ago
friday +171% / $11 and $Q_BTS follows on Monday, which is much better than QMCO and still has a lot of potential to trade above $10 ?
all only imho

here: https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175432596


QMCO
Whalatane Whalatane 2 hours ago
Yes There will be less of a reaction in the UNCY stock for the reason you mentioned
ARDX is saying they will supply Xphozah free of charge to Medicare patients who lose coverage in Jan ...for the first 2 mths only
Nephrologists are probably already pulling back from starting Medicare
ARDX UNCY
SCAMBUSTERKING SCAMBUSTERKING 2 hours ago
My statements are backed up by the court docs filed by Jake and his lawyer... then even more proven by the actions of Jake.
BCAP
chereb19 chereb19 2 hours ago
An even bigger Whopper of a lie. Can't believe anything you write, there's are too many examples of your lies. Dishonest and incompetent?
RDGL
knrorrel knrorrel 2 hours ago
THE $QBTS TREND https://stockcharts.com/sc3/ui/?s=QBTS
QBTS
weedtrader420 weedtrader420 2 hours ago
☝️🤑☝️📈🚀
SUKUUSD
knrorrel knrorrel 2 hours ago
THE $QBTS TREND https://stockcharts.com/sc3/ui/?s=QBTS
QBTS
fuagf fuagf 2 hours ago
And all should understand subsidies discourage innovation leading to efficiency.
You're right too, we are talking about corporate farming in that respect also.
Ray_137 Ray_137 2 hours ago
That can be true plan 7 contains some parts of plan6. Investors in WAMU signed releases based on plan7.
COOP
Kam8 Kam8 2 hours ago
I am guessing $2+ after approval in UK, not only 27cents. 
NWBO
dstock07734 dstock07734 2 hours ago
George,

It could be none of them.
NWBO
snoopycomic snoopycomic 3 hours ago
Dufus- OS is the measurement.
NWBO

Your Recent History

Delayed Upgrade Clock